| Blue native polyacrylamide gel electrophoresis (BN-PAGE) for the identification and analysis of multiprotein complexes M Swamy, GM Siegers, S Minguet, B Wollscheid, WWA Schamel Science's STKE 2006 (345), pl4-pl4, 2006 | 178 | 2006 |
| Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker M Schneider, J Huber, B Hadaschik, GM Siegers, HH Fiebig, J Schüler BMC cancer 12, 1-11, 2012 | 140 | 2012 |
| Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells GM Siegers, H Dhamko, XH Wang, AM Mathieson, Y Kosaka, ... Cytotherapy 13 (6), 753-764, 2011 | 107 | 2011 |
| Nodal signalling in embryogenesis and tumourigenesis DF Quail, GM Siegers, M Jewer, LM Postovit The international journal of biochemistry & cell biology 45 (4), 885-898, 2013 | 106 | 2013 |
| Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field? GM Siegers, LS Lamb Molecular Therapy 22 (8), 1416-1422, 2014 | 99 | 2014 |
| Translational control of breast cancer plasticity M Jewer, L Lee, M Leibovitch, G Zhang, J Liu, SD Findlay, KM Vincent, ... Nature communications 11 (1), 2498, 2020 | 88 | 2020 |
| Different composition of the human and the mouse γδ T cell receptor explains different phenotypes of CD3γ and CD3δ immunodeficiencies GM Siegers, M Swamy, E Fernández-Malavé, S Minguet, S Rathmann, ... The Journal of experimental medicine 204 (11), 2537-2544, 2007 | 73 | 2007 |
| Human gamma delta T regulatory cells in cancer: fact or fiction? D Wesch, C Peters, GM Siegers Frontiers in immunology 5, 120764, 2014 | 71 | 2014 |
| Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRI GM Siegers, EJ Ribot, A Keating, PJ Foster Cancer Immunology, Immunotherapy 62, 571-583, 2013 | 59 | 2013 |
| The CD3 conformational change in the γδ T cell receptor is not triggered by antigens but can be enforced to enhance tumor killing EP Dopfer, FA Hartl, HH Oberg, GM Siegers, OS Yousefi, S Kock, GJ Fiala, ... Cell reports 7 (5), 1704-1715, 2014 | 56 | 2014 |
| Embryonic morphogen nodal promotes breast cancer growth and progression DF Quail, G Zhang, LA Walsh, GM Siegers, DZ Dieters-Castator, ... PloS one 7 (11), e48237, 2012 | 50 | 2012 |
| Proteomics-derived biomarker panel improves diagnostic precision to classify endometrioid and high-grade serous ovarian carcinoma DZ Dieters-Castator, PF Rambau, LE Kelemen, GM Siegers, GA Lajoie, ... Clinical Cancer Research 25 (14), 4309-4319, 2019 | 47 | 2019 |
| Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+ leukemia model GM Siegers, TC Felizardo, AM Mathieson, Y Kosaka, XH Wang, JA Medin, ... PLoS One 6 (2), e16700, 2011 | 47 | 2011 |
| Intratibial injection of human multiple myeloma cells in NOD/SCID IL-2Rγ (null) mice mimics human myeloma and serves as a valuable tool for the development of anticancer strategies J Schueler, D Wider, K Klingner, GM Siegers, AM May, R Wäsch, ... PloS one 8 (11), e79939, 2013 | 39 | 2013 |
| A native antibody-based mobility-shift technique (NAMOS-assay) to determine the stoichiometry of multiprotein complexes M Swamy, S Minguet, GM Siegers, B Alarcón, WWA Schamel Journal of immunological methods 324 (1-2), 74-83, 2007 | 39 | 2007 |
| Functional plasticity of gamma delta T cells and breast tumor targets in hypoxia GM Siegers, I Dutta, R Lai, LM Postovit Frontiers in immunology 9, 371670, 2018 | 35 | 2018 |
| Identification of disulfide bonds in the Ig-α/Ig-β component of the B cell antigen receptor using the Drosophila S2 cell reconstitution system GM Siegers, J Yang, CU Duerr, PJ Nielsen, M Reth, WWA Schamel International immunology 18 (9), 1385-1396, 2006 | 30 | 2006 |
| Integral roles for integrins in γδ T cell function GM Siegers Frontiers in Immunology 9, 351664, 2018 | 22 | 2018 |
| Illuminating luminal B: QSOX1 as a subtype-specific biomarker P Das, GM Siegers, LM Postovit Breast Cancer Research 15, 1-3, 2013 | 20 | 2013 |
| Suppressive activity of Vδ2+ γδ T cells on αβ T cells is licensed by TCR signaling and correlates with signal strength K Schilbach, N Krickeberg, C Kaißer, S Mingram, J Kind, GM Siegers, ... Cancer Immunology, Immunotherapy 69, 593-610, 2020 | 18 | 2020 |
Lynne PostovitQueen's UniversityVerified email at queensu.ca
